JP2002501530A5 - - Google Patents

Download PDF

Info

Publication number
JP2002501530A5
JP2002501530A5 JP1999500722A JP50072299A JP2002501530A5 JP 2002501530 A5 JP2002501530 A5 JP 2002501530A5 JP 1999500722 A JP1999500722 A JP 1999500722A JP 50072299 A JP50072299 A JP 50072299A JP 2002501530 A5 JP2002501530 A5 JP 2002501530A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1999500722A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002501530A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/009889 external-priority patent/WO1998054161A1/en
Publication of JP2002501530A publication Critical patent/JP2002501530A/ja
Publication of JP2002501530A5 publication Critical patent/JP2002501530A5/ja
Withdrawn legal-status Critical Current

Links

JP50072299A 1997-05-30 1998-05-18 チオカルボニル官能基を有するオキサゾリジノン抗菌剤 Withdrawn JP2002501530A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4834297P 1997-05-30 1997-05-30
US60/048,342 1997-05-30
PCT/US1998/009889 WO1998054161A1 (en) 1997-05-30 1998-05-18 Oxazolidinone antibacterial agents having a thiocarbonyl functionality

Publications (2)

Publication Number Publication Date
JP2002501530A JP2002501530A (ja) 2002-01-15
JP2002501530A5 true JP2002501530A5 (enExample) 2005-12-08

Family

ID=21954059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50072299A Withdrawn JP2002501530A (ja) 1997-05-30 1998-05-18 チオカルボニル官能基を有するオキサゾリジノン抗菌剤

Country Status (19)

Country Link
US (1) US6218413B1 (enExample)
EP (1) EP0984947B8 (enExample)
JP (1) JP2002501530A (enExample)
KR (1) KR20010013192A (enExample)
CN (1) CN1138765C (enExample)
AT (1) ATE293609T1 (enExample)
AU (1) AU737995B2 (enExample)
BR (1) BR9815518A (enExample)
CA (1) CA2288750A1 (enExample)
DE (1) DE69829846T2 (enExample)
ES (1) ES2242280T3 (enExample)
FI (1) FI19992555L (enExample)
HU (1) HUP0001393A3 (enExample)
NO (1) NO315798B1 (enExample)
NZ (1) NZ501412A (enExample)
PL (1) PL337329A1 (enExample)
RU (1) RU2208613C2 (enExample)
SK (1) SK156499A3 (enExample)
WO (1) WO1998054161A1 (enExample)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2228647A1 (en) * 1995-09-01 1997-03-13 Pharmacia & Upjohn Company Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
DK1054874T3 (da) * 1998-02-13 2002-12-30 Upjohn Co Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
AU3180999A (en) * 1998-02-25 1999-09-15 Pharmacia & Upjohn Company Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
SK18362000A3 (sk) 1998-06-05 2001-06-11 Astrazeneca Ab Oxazolidinónové deriváty, spôsob ich prípravy a farmaceutické kompozície, ktoré ich obsahujú
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体
WO2000029396A1 (de) * 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue substituierte phenyloxazolidon-derivate
WO2000029409A1 (de) * 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue heterocyclyl-substituierte oxazolidon-derivate
JP2002531455A (ja) * 1998-11-27 2002-09-24 ファルマシア・アンド・アップジョン・カンパニー チオカルボニル官能基を有するオキサゾリジノン抗細菌剤
EP1200416A1 (en) 1999-07-28 2002-05-02 Pharmacia & Upjohn Company Oxazolidinones and their use as antiinfectives
US6297242B1 (en) * 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
US6413981B1 (en) 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
MY120189A (en) 1999-11-04 2005-09-30 Upjohn Co Sultam and sultone derived oxazolidinones
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
PE20010851A1 (es) * 1999-12-14 2001-08-17 Upjohn Co Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
EP1242417A1 (en) * 1999-12-21 2002-09-25 PHARMACIA & UPJOHN COMPANY Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
CN1395569A (zh) * 2000-02-10 2003-02-05 法玛西雅厄普约翰美国公司 含有哌嗪酰胺取代基的噁唑二酮硫代酰胺
US6642238B2 (en) * 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
AU2001253113B2 (en) * 2000-04-20 2005-02-03 Pharmacia & Upjohn Company Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6562820B2 (en) 2000-07-05 2003-05-13 Pharmacia & Upjohn Company Method for treatment and prevention of mastitis
CZ2003228A3 (cs) * 2000-07-17 2003-06-18 Ranbaxy Laboratories Limited Oxazolidinonové deriváty jako antimikrobiální látky
PE20020689A1 (es) 2000-11-17 2002-08-03 Upjohn Co Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno
CA2405532A1 (en) 2001-02-07 2002-08-22 Ortho-Mcneil Pharmaceutical, Inc. Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
WO2002081470A1 (en) * 2001-04-07 2002-10-17 Astrazeneca Ab Oxazolidinones containing a sulfonimid group as antibiotics
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
AU2002319848A1 (en) * 2002-07-29 2004-02-25 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US7094900B2 (en) 2002-08-12 2006-08-22 Pharmacia & Upjohn Company Llc N-Aryl-2-oxazolidinones and their derivatives
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
AU2003265090A1 (en) 2002-10-10 2004-05-04 Pharmacia & Upjohn Comapny LLC Antimicrobial 1-aryl dihydropyridone compounds
AR042086A1 (es) 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
GB0229521D0 (en) * 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
BRPI0409217A (pt) 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
MXPA05013132A (es) 2003-06-03 2006-05-25 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo y metodos de produccion y su uso.
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
WO2005019214A1 (en) * 2003-08-25 2005-03-03 Warner-Lambert Company Llc Novel antimicrobial aryloxazolidinone compounds
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
US7129259B2 (en) 2003-12-17 2006-10-31 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
WO2005082900A2 (en) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) * 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
US7592335B2 (en) 2005-04-15 2009-09-22 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
US8399660B2 (en) 2005-06-08 2013-03-19 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
RU2578602C2 (ru) 2005-10-04 2016-03-27 Байер Интеллектуэль Проперти Гмбх Способ получения 5-хлор-n-(5s)-2-оксо-3-[4-(3-оксо-морфолинил)-фенил]-1,3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида в модификации ii (варианты)
US8148362B2 (en) * 2006-03-31 2012-04-03 Research Foundation Itsuu Laboratory Compound having heterocyclic ring
WO2009001192A2 (en) * 2007-06-22 2008-12-31 Orchid Research Laboratories Limited Novel compounds and their use
WO2009044777A1 (ja) 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory 7員ヘテロ環を有するオキサゾリジノン誘導体
EP2655362A1 (en) 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
US9233989B2 (en) * 2011-10-11 2016-01-12 Council Of Scientific & Industrial Research Sila analogs of oxazolidinone derivatives and synthesis thereof
CN103360294B (zh) * 2012-03-28 2015-11-25 复旦大学 具有抗结核活性的化合物及其制备方法和应用
CN103044341B (zh) * 2012-12-20 2015-07-01 郑州大学 1,2,3-三唑-氨基二硫代甲酸酯-脲复合体、其制备方法及其应用
CA2922567A1 (en) * 2013-08-26 2015-03-05 Purdue Pharma L.P. Azaspiro[4.5]decane derivatives and use thereof
CN108299329A (zh) * 2018-03-28 2018-07-20 许传森 一种噁唑酮类衍生物及其在抗菌药物中的应用
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent
CN115466253B (zh) * 2021-06-16 2024-08-20 沈阳药科大学 含二硫代氨基甲酸酯结构的噁唑烷酮类化合物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8506659A1 (es) 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
CA1260948A (en) * 1984-12-05 1989-09-26 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
EP0609905B1 (en) * 1988-09-15 2001-06-06 PHARMACIA & UPJOHN COMPANY 3-(Nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
DE4425612A1 (de) 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
CA2228647A1 (en) * 1995-09-01 1997-03-13 Pharmacia & Upjohn Company Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
GB9521508D0 (en) * 1995-10-20 1995-12-20 Zeneca Ltd Chemical compounds
DE19601264A1 (de) * 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
ES2186916T3 (es) 1996-08-21 2003-05-16 Upjohn Co Derivados de isoxazolina como agentes antimicrobianos.

Similar Documents

Publication Publication Date Title
JP2000509912A5 (enExample)
JP2000509942A5 (enExample)
JP2000510751A5 (enExample)
JP2000507042A5 (enExample)
JP2001515417A5 (enExample)
JP2002501530A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2002508659A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2000509520A5 (enExample)
JP2000507434A5 (enExample)
JP2001511002A5 (enExample)
JP2000508880A5 (enExample)
JP2000510792A5 (enExample)
JP2000509958A5 (enExample)